(CRMD) CorMedix - Performance 258.1% in 12m
CRMD performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
42.62%
#21 in Peer-Group
Rel. Strength
98.34%
#125 in Stock-Universe
Total Return 12m
258.13%
#5 in Peer-Group
Total Return 5y
142.63%
#11 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 56.6 |
| P/E Forward | 22.1 |
| High / Low | USD |
|---|---|
| 52 Week High | 16.56 USD |
| 52 Week Low | 3.64 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 64.86 |
| Buy/Sell Signal +-5 | 0.00 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CRMD (258.1%) vs XLV (-7.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-3.67% | 143% | 342% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
9.25% | -11.8% | 416% | 63.7 | 36 | 1.2 | 58.2% | 18.9% |
| NVS NYSE Novartis |
4.23% | 13.9% | 74.9% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
1.41% | 2.61% | 46.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| GSK NYSE GlaxoSmithKline |
-2.94% | -0.85% | 47.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| SFZN SW Siegfried Holding |
-7.61% | -1.2% | 117% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| AZN NASDAQ AstraZeneca |
-1.8% | -10.9% | 47.7% | 28.5 | 15.7 | 0.95 | 52.7% | 22.3% |
| IPN PA Ipsen |
1.16% | -10.2% | 43.5% | 24.1 | 10.2 | 0.73 | -6.40% | -6.33% |
Performance Comparison: CRMD vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for CRMD
| Total Return (including Dividends) | CRMD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 19.47% | 1.80% | 3.01% |
| 3 Months | 103.95% | -7.39% | 5.82% |
| 12 Months | 258.13% | -7.13% | 12.82% |
| 5 Years | 142.63% | 47.29% | 114.16% |
| Trend Score (consistency of price movement) | CRMD | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 79.9% | 48.3% | 79.1% |
| 3 Months | 97.7% | -54.2% | 89.5% |
| 12 Months | 68.4% | -70.1% | 43.8% |
| 5 Years | 2.4% | 88.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #26 | 17.36% | 15.99% |
| 3 Month | #3 | 120.22% | 92.74% |
| 12 Month | #5 | 285.62% | 217.43% |
| 5 Years | #12 | 64.73% | 13.29% |
FAQs
Does CorMedix (CRMD) outperform the market?
Yes,
over the last 12 months CRMD made 258.13%, while its related Sector, the Health Care Sector SPDR (XLV) made -7.13%.
Over the last 3 months CRMD made 103.95%, while XLV made -7.39%.
Performance Comparison CRMD vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CRMD vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 8.3% | 16.5% | 74.6% | 245% |
| US NASDAQ 100 | QQQ | 7.8% | 15.5% | 73.7% | 245% |
| German DAX 40 | DAX | 9.5% | 22.5% | 58.9% | 229% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.7% | 15.2% | 74% | 239% |
| Hongkong Hang Seng | HSI | 5.9% | 11.3% | 55.5% | 223% |
| India NIFTY 50 | INDA | 8% | 18.6% | 72.8% | 258% |
| Brasil Bovespa | EWZ | 12.1% | 19.1% | 52.5% | 252% |
CRMD vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.3% | 15.9% | 69.3% | 234% |
| Consumer Discretionary | XLY | 8.8% | 21% | 84.5% | 239% |
| Consumer Staples | XLP | 9.8% | 21.4% | 74.2% | 252% |
| Energy | XLE | 13.5% | 16.4% | 74.6% | 263% |
| Financial | XLF | 7.5% | 18.2% | 70.7% | 232% |
| Health Care | XLV | 9.3% | 17.7% | 79.4% | 265% |
| Industrial | XLI | 8.8% | 18.8% | 68.4% | 239% |
| Materials | XLB | 10% | 19.4% | 73.5% | 258% |
| Real Estate | XLRE | 10.8% | 18.8% | 73.7% | 245% |
| Technology | XLK | 6.9% | 11.9% | 72.2% | 247% |
| Utilities | XLU | 9.6% | 20.2% | 69.1% | 238% |
| Aerospace & Defense | XAR | 7.6% | 14.7% | 57.7% | 214% |
| Biotech | XBI | 9.5% | 14.5% | 86.2% | 269% |
| Homebuilder | XHB | 6.2% | 19.2% | 84.5% | 261% |
| Retail | XRT | 9.8% | 19.1% | 82.2% | 255% |
CRMD vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 21.1% | 10.5% | 75.9% | 265% |
| Natural Gas | UNG | 22.6% | 26.6% | 73% | 275% |
| Gold | GLD | 11.3% | 18.6% | 49.8% | 215% |
| Silver | SLV | 11% | 10.3% | 54.5% | 233% |
| Copper | CPER | 8.6% | 15.4% | 56.9% | 244% |
CRMD vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 9.3% | 17% | 74.7% | 262% |
| iShares High Yield Corp. Bond | HYG | 9.5% | 18.1% | 72% | 248% |